Target Name: MIR3158-1
NCBI ID: G100422900
Review Report on MIR3158-1 Target / Biomarker Content of Review Report on MIR3158-1 Target / Biomarker
MIR3158-1
Other Name(s): microRNA 3158-1 | hsa-miR-3158-3p | hsa-mir-3158-1 | MicroRNA 3158-1 | hsa-miR-3158-5p | mir-3158-1

MIR3158-1: A Drug Target / Disease Biomarker

MIR3158-1, also known as interleukin-31 (IL-31), is a protein that is expressed in various tissues throughout the body, including the lungs, heart, kidneys, and intestines. It is a member of the interleukin family, which is a group of cytokines that play a crucial role in the immune system and other physiological processes.

One of the things that makes IL-31 an attractive drug target is its role in the regulation of inflammation. IL-31 has been shown to play a key role in the recruitment of immune cells to the site of inflammation, as well as in the production of inflammatory cytokines. This makes it an attractive target for drugs that are designed to suppress inflammation and improve tissue repair.

Another potential mechanism by which IL-31 may be targeted is its role in the regulation of cell survival. IL-31 has been shown to promote the survival of various cell types, including immune cells and cancer cells. This suggests that it may be a useful target for drugs that are designed to inhibit cell survival and promote cell death.

In addition to its potential as a drug target, IL-31 is also a potential biomarker. The level of IL-31 in tissues can be used as a diagnostic marker for a variety of diseases, including cancer, autoimmune disorders, and respiratory diseases. This makes it an attractive target for diagnostic tests that are designed to measure the level of IL-31 in the body.

Overall, the potential targets for IL-31 make it an interesting molecule for research and development. Further studies are needed to fully understand the role of IL-31 in various biological processes and to identify potential drugs that can effectively target it.

Protein Name: MicroRNA 3158-1

The "MIR3158-1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3158-1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR3158-2 | MIR3159 | MIR3160-1 | MIR3160-2 | MIR3161 | MIR3162 | MIR3163 | MIR3164 | MIR3165 | MIR3166 | MIR3167 | MIR3168 | MIR3169 | MIR3170 | MIR3171 | MIR3171HG | MIR3173 | MIR3174 | MIR3175 | MIR3176 | MIR3177 | MIR3178 | MIR3179-1 | MIR3179-2 | MIR3179-3 | MIR3180-1 | MIR3180-2 | MIR3180-3 | MIR3180-4 | MIR3180-5 | MIR3182 | MIR3183 | MIR3184 | MIR3185 | MIR3186 | MIR3187 | MIR3188 | MIR3189 | MIR3190 | MIR3191 | MIR3192 | MIR3193 | MIR3194 | MIR3195 | MIR3196 | MIR3197 | MIR3198-1 | MIR3199-1 | MIR3199-2 | MIR31HG | MIR32 | MIR3200 | MIR3201 | MIR3202-1 | MIR3202-2 | MIR320A | MIR320B1 | MIR320B2 | MIR320C1 | MIR320C2 | MIR320D1 | MIR320D2 | MIR320E | MIR323A | MIR323B | MIR324 | MIR325 | MIR325HG | MIR326 | MIR328 | MIR329-1 | MIR329-2 | MIR330 | MIR331 | MIR335 | MIR337 | MIR338 | MIR339 | MIR33A | MIR33B | MIR340 | MIR342 | MIR345 | MIR346 | MIR34A | MIR34AHG | MIR34B | MIR34C | MIR3529 | MIR3591 | MIR3605 | MIR3606 | MIR3609 | MIR361 | MIR3610 | MIR3611 | MIR3612 | MIR3613 | MIR3614 | MIR3615